Sign in

Tom Marjot

@tom-marjot.bsky.social
479 followers 440 following 11 posts

Liver doctor. NIHR Academic Clinical Lecturer at University of Oxford. Interested in #MASLD, #circadian rhythms, & #sleep. #EASL YI Taskforce.

PostsRepliesMedia
Tom Marjot @tom-marjot.bsky.social · 11/08/2025
Really nice to be hosting the BASL #MASLD SIG at Jesus College Oxford on 5th September 📢Attendance is FREE and registration is EASY. There are still a few spaces left. 🔗(tinyurl.com/4j8esadr) Really great mix of speakers. AM = Basic/Translational science; PM = Clinical updates
Programme for BASL MASLD SIG meeting 5th September 2025Venue details for BASL MASLD SIG meeting 5th September 2025
020
Tom Marjot @tom-marjot.bsky.social · 25/05/2025
📢Great to write this review for Hep Comms with Matt Armstrong & @jonathanstinemd.bsky.social 💪We've covered everything you need to know about #Muscle & #MASLD - Insulin resistance - Sarcopenia - Myosteatosis - Impact of weight loss drugs - Benefits of exercise 🔗 shorturl.at/aFO1Q #LiverSky
Graphic showing assessment methods for various domains of muscle quality and function in patients with MASLD including insulin resistance, myosteatosis, sarcopenia, and frailty.
1112
Reposted by Tom Marjot
Jonathan G. Stine, MD MSc, FACP @jonathanstinemd.bsky.social · 23/05/2025
It was an absolute delight to contribute to this high-impact work with @tom-marjot.bsky.social and @mattarmstrong95.bsky.social in which we review all things #MASLD and #Muscle! If you're looking for holiday weekend reading, look no further: journals.lww.com/hepcomm/page... @ebtapper.bsky.social
journals.lww.com
Skeletal muscle and MASLD: Mechanistic and clinical insights : Hepatology Communications
, which all converge on the liver to drive disease progression and adverse patient outcomes. This review explores the mechanistic links between skeletal muscle and MASLD, including the role of abnorma...
082
Reposted by Tom Marjot
Rui Castro @ruicastrohd.bsky.social · 15/04/2025
BS @easlnews.bsky.social Congress Wed 7🗓️Whole-day seminar plus a wet lab on spatial biology (NEW THIS YEAR‼️) Thu 8🗓️State of the Art by Lars Zender Fri 9🗓️MTE sessions on MASLD & MetALD Sat 10🗓️Microbiome session co-chaired by our own @debbieshawcross.bsky.social & more!🔗https://tinyurl.com/4ky9r3x9
194
Reposted by Tom Marjot
Eric Topol @erictopol.bsky.social · 06/03/2025
In these unprecedented dark times for American life science and medical research (no less well beyond biomedicine), my coping mechanism is to laser focus on the unremitting and remarkable daily advances, and the fervent hope these will not be slowed or interrupted.
281280152
Tom Marjot @tom-marjot.bsky.social · 17/03/2025
#LiverSky
020
Tom Marjot @tom-marjot.bsky.social · 17/03/2025
Breakthroughs Beyond the Journal @jhepatology.bsky.social 🚨The liver is central to fructose-associated cancer ▶️Tumors cannot use fructose directly ▶️Liver converts to specific lipids (LPC) ▶️LPCs integrate into new cancer membranes Can this explain link between MASLD & extra-hepatic cancer?
Highlights from latest article in Breakthroughs Beyond the Journal in Journal of Hepatology. It showcases work published in Nature.
161
Reposted by Tom Marjot
Elliot Tapper @ebtapper.bsky.social · 25/01/2025
There has been a recent influx to #gisky and #liversky To sustain this, you need to be active. If you were a lurker, no we need your pearls, papers, and pets. Post. Use the hashtags. Build.
14715
Reposted by Tom Marjot
Rui Castro @ruicastrohd.bsky.social · 24/01/2025
Young Investigator Poster Tour @easlnews.bsky.social #SLDSummit Huge attendance and interest! 👏🏼 @tom-marjot.bsky.social @madsisraelsen.bsky.social
042
Reposted by Tom Marjot
EASL @easlnews.bsky.social · 15/01/2025
2025 is the perfect year to take your career to the next level🚀 There are also 6 positions to fill in the EASL Scientific Committee, Policy Public Health and Advocacy Committee, Ethics and Compliance Committee and Nurses & AHPs Task Force. Apply by 20 January: easl.eu/leadership25 #LiverSky
0125
Reposted by Tom Marjot
Nature Reviews Gastroenterology & Hepatology @natrevgastrohep.nature.com · 06/01/2025
By @adhanda.bsky.social & @tom-marjot.bsky.social #Sharedit link: rdcu.be/d5rwu
rdcu.be
Alcohol-free and low-strength drinks: friend or foe?
Nature Reviews Gastroenterology & Hepatology - Consumption of no and low-alcohol (NoLo) beverages is now commonplace in modern society. However, the debate surrounding the relative risks and...
084
Reposted by Tom Marjot
Adlung Lab @adlunglab.com · 05/01/2025
Thoughtful piece from Marjot & Dhanda (@adhanda.bsky.social) in @natrevgastrohep.bsky.social: Alcohol-free drinks show promise for motivated individuals to reduce alcohol consumption but may pose relapse risks in others. Balance is key for clinical guidance. 🧪 www.nature.com/articles/s41...
nature.com
Alcohol-free and low-strength drinks: friend or foe? - Nature Reviews Gastroenterology & Hepatology
Consumption of no and low-alcohol (NoLo) beverages is now commonplace in modern society. However, the debate surrounding the relative risks and benefits of these products is nuanced and evolving, part...
263
Reposted by Tom Marjot
Ashwin Dhanda @adhanda.bsky.social · 03/01/2025
Do read my comment piece with @tom-marjot.bsky.social on NoLo alcohol 👇🏾
164
Tom Marjot @tom-marjot.bsky.social · 02/01/2025
1: In 2025, look out for a new section in Journal of Hepatology: "Breakthroughs Beyond the Journal". Editorial-style analyses of pivotal liver research. #LiverSky 2: My comment on work from Cell Metabolism showing that MI drives #MASH. The interaction between these two conditions works BOTH ways👇
New evidence of cross-disease communication between heart and liver
1121
Tom Marjot @tom-marjot.bsky.social · 17/12/2024
Good to see you here @easlnews.bsky.social !
041
Reposted by Tom Marjot
NEJM.org @nejm.org · 06/12/2024
Hello, #MedSky community! We’re excited to begin our Bluesky journey. Here is a sampling of the trusted, influential, and essential information you can expect when you follow us:
32860187
Reposted by Tom Marjot
Jonathan G. Stine, MD MSc, FACP @jonathanstinemd.bsky.social · 27/11/2024
#LiverSky Come join in T-minus 26 mins for EASL Studio! #Sarcopenia #Exercise #Nutrition #Frailty #MASLD #LiverTransplant
021
Reposted by Tom Marjot
Andrew Moon @andrewmmoon.bsky.social · 27/11/2024
Tumor seeding is a dreaded complication of biopsy for HCC. But how common is it? A systematic review in @amcollegegastro.bsky.social #AmJGastro reports a rate of tumor seeding of 0.62% with even lower rates in recent years #LiverSky Link: journals.lww.com/ajg/abstract...
0199
Tom Marjot @tom-marjot.bsky.social · 26/11/2024
#LiverSky Useful tip... There's no 'bookmark' function in Bluesky currently. But there is a nice work-around: 1) Reply to the post of interest with a📌emoji 2) Click on this link bsky.app/profile/did:... 3) Click 'Pin to Home' This will collate📌posts in a tab on your home screen + ⬆️ engagement.
9208
Reposted by Tom Marjot
Atoosa Rabiee @atoosarabiee.bsky.social · 20/11/2024
1/3 What happens when science and every day clinical practice comes together? A 🧵 You get a packed room with not even a place to stand 👇🏼 Why? I firmly believe that we need to bridge the gap between research and clinical application in our scientific meetings. #TLM24
1123
Reposted by Tom Marjot
Elisabeth Bik @elisabethbik.bsky.social · 20/11/2024
This artwork was published in the Journal of Immunology, published by @immunologyaai.bsky.social - which appears not to give a fork. pubpeer.com/publications... The Chinese government also did not see any problem. www.science.org/content/arti... #ThisImageIsFine
A figure from a scientific paper showing a single Flow Cytometry (FACS) panel. It looks like lots of dots in a square. Unexpectedly, some constellations of dots appear to be copy/pasted, and I have marked those with rounded boxes of the same color. A figure from a scientific paper showing four Flow Cytometry (FACS) panels. Each looks like lots of dots in a square. Unexpectedly, some constellations of dots appear to be copy/pasted, and I have marked those with rounded boxes of the same color.
3305
Reposted by Tom Marjot
Brian Moore @brianmoore666.bsky.social · 19/11/2024
This is hypnotic bcounter.nat.vg
bcounter.nat.vg
Bcounter
Almost-real-time Bluesky user count
1515333
Reposted by Tom Marjot
Elliot Tapper @ebtapper.bsky.social · 15/11/2024
We are on our second starter pack for GI / Hepatology Part 1: go.bsky.app/8Pho2tp Part 2: go.bsky.app/VGyLKjR #medsky #GIsky #LiverSky
239932